ECB-ART-52486
Crit Care
2023 Jun 13;271:234. doi: 10.1186/s13054-023-04525-3.
Show Gene links
Show Anatomy links
Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis.
???displayArticle.abstract???
Angiopoietin-2 (Ang-2) is associated with vascular endothelial injury and permeability in the acute respiratory distress syndrome (ARDS) and sepsis. Elevated circulating Ang-2 levels may identify critically ill patients with distinct pathobiology amenable to targeted therapy. We hypothesized that plasma Ang-2 measured shortly after hospitalization among patients with sepsis would be associated with the development of ARDS and poor clinical outcomes. To test this hypothesis, we measured plasma Ang-2 in a cohort of 757 patients with sepsis, including 267 with ARDS, enrolled in the emergency department or early in their ICU course before the COVID-19 pandemic. Multivariable models were used to test the association of Ang-2 with the development of ARDS and 30-day morality. We found that early plasma Ang-2 in sepsis was associated with higher baseline severity of illness, the development of ARDS, and mortality risk. The association between Ang-2 and mortality was strongest among patients with ARDS and sepsis as compared to those with sepsis alone (OR 1.81 vs. 1.52 per log Ang-2 increase). These findings might inform models testing patient risk prediction and strengthen the evidence for Ang-2 as an appealing biomarker for patient selection for novel therapeutic agents to target vascular injury in sepsis and ARDS.
???displayArticle.pubmedLink??? 37312169
???displayArticle.link??? Crit Care
???displayArticle.grants???
References [+] :
Agrawal,
Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.
2013, Pubmed